MiNK Therapeutics's total assets for Q3 2024 were $7.37M, a decrease of -28.56% from the previous quarter. INKT total liabilities were $24.93M for the fiscal quarter, a -7.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.